Viewing Study NCT04657861


Ignite Creation Date: 2025-12-24 @ 12:46 PM
Ignite Modification Date: 2026-02-22 @ 9:05 AM
Study NCT ID: NCT04657861
Status: RECRUITING
Last Update Posted: 2022-05-09
First Post: 2020-10-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma
Sponsor: Zhejiang University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma in Relapse View
None Multiple Myeloma, Refractory View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None CAR T-cell therapy View
None BCMA/TACI positive View